Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Current Leases: 2019-2024

Historic Current Leases for Editas Medicine (EDIT) over the last 6 years, with Dec 2024 value amounting to $14.7 million.

  • Editas Medicine's Current Leases fell 62.86% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year decrease of 62.86%. This contributed to the annual value of $14.7 million for FY2024, which is 20.45% up from last year.
  • As of FY2024, Editas Medicine's Current Leases stood at $14.7 million, which was up 20.45% from $12.2 million recorded in FY2023.
  • Editas Medicine's Current Leases' 5-year high stood at $14.7 million during FY2024, with a 5-year trough of $6.8 million in FY2020.
  • Moreover, its 3-year median value for Current Leases was $12.2 million (2023), whereas its average is $12.6 million.
  • Data for Editas Medicine's Current Leases shows a peak YoY spiked of 51.36% (in 2021) over the last 5 years.
  • Over the past 5 years, Editas Medicine's Current Leases (Yearly) stood at $6.8 million in 2020, then skyrocketed by 51.36% to $10.3 million in 2021, then increased by 7.50% to $11.1 million in 2022, then grew by 9.76% to $12.2 million in 2023, then increased by 20.45% to $14.7 million in 2024.